CASP3 and melanoma: Additionally, treatment of wild-type melanoma cells simultaneously with CsA and CisPt or CsA and DOX increases caspase 3/7 activity and reduces the survival of melanoma cells compared to RIPK4.KO cells, regardless of the melanoma cell lines studied.